Cary Street Partners Asset Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-4,140
| Closed | -$225K | – | 204 |
|
|
2024
Q1 | $225K | Sell |
4,140
-885
| -18% | -$48K | 0.03% | 185 |
|
|
2023
Q4 | $258K | Sell |
5,025
-2,050
| -29% | -$105K | 0.04% | 183 |
|
|
2023
Q3 | $411K | Sell |
7,075
-33,395
| -83% | -$1.94M | 0.08% | 154 |
|
|
2023
Q2 | $2.59M | Sell |
40,470
-101
| -0.2% | -$6.46K | 0.48% | 55 |
|
|
2023
Q1 | $2.81M | Sell |
40,571
-4,265
| -10% | -$296K | 0.53% | 49 |
|
|
2022
Q4 | $3.23M | Buy |
44,836
+6,266
| +16% | +$451K | 0.65% | 41 |
|
|
2022
Q3 | $2.74M | Sell |
38,570
-255
| -0.7% | -$18.1K | 0.66% | 42 |
|
|
2022
Q2 | $2.99M | Sell |
38,825
-13,281
| -25% | -$1.02M | 0.7% | 39 |
|
|
2022
Q1 | $3.81M | Sell |
52,106
-1,305
| -2% | -$95.3K | 0.76% | 40 |
|
|
2021
Q4 | $3.33M | Sell |
53,411
-29,013
| -35% | -$1.81M | 0.71% | 43 |
|
|
2021
Q3 | $4.88M | Buy |
82,424
+2,394
| +3% | +$142K | 1.72% | 19 |
|
|
2021
Q2 | $5.35M | Sell |
80,030
-89,132
| -53% | -$5.96M | 1.28% | 24 |
|
|
2021
Q1 | $4.45M | Buy |
169,162
+9,432
| +6% | +$248K | 1.09% | 29 |
|
|
2020
Q4 | $4.21M | Buy |
+159,730
| New | +$4.21M | 1.24% | 26 |
|